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Introduction
Neural tube defects (NTDs) have an incidence of 1–2
per 1,000 births and are considered to be a heteroge-
neous condition resulting from failure of normal neu-
ral tube closure between the third and fourth week of
embryonic development. The three common types of
NTDs are anencephaly, spina bifida and encephalo-
cele, while less common types include amniotic band
syndrome, limb–body wall complex, cloacal exstrophy
or omphalocele-exstrophy-imperforate anus-spinal de-
fects complex and other types of spinal abnormalities.
The incidence of NTDs varies with race, geographic
location, socioeconomic class, nutritional status, and
multiple predisposing factors such as single gene 
disorders, chromosomal abnormalities, teratogens, ma-
ternal diabetes, family history of NTDs, and polymor-
phisms in the genes controlling folate metabolism. There
is considerable evidence to suggest that genetic and
environmental factors contribute to the etiology of
NTDs. NTDs may be associated with maternal and fetal
risk factors.
Maternal Fumonisin Consumption
Fumonisins are a family of mycotoxins produced by the
fungus Fusarium verticillioides, which can infect corns and
cause diseases of corn ears, stalks and seedlings [1].
Unintended consumption of contaminated corns or corn
products may result in cancer, diseases, and congenital
anomalies in humans and animals [2]. Fumonisin con-
sumption is a risk factor for human NTDs, especially in
combination with other risk factors such as genetic
susceptibility and folate deficiency [2]. A relationship
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between maternal fumonisin consumption and NTDs
is most evident among populations that consume the
highest amounts of corns, such as those of Texas–Mexico
border, Central and South America, South Africa, and
northern provinces of China [3–8]. Hendricks [5]
found that corn meal samples collected in the United
States during the NTD outbreak between 1990 and
1991 had a relatively high level of fumonisins. Missmer
et al [8] found that during the NTD outbreak along the
Texas–Mexico border between 1990 and 1991, moder-
ate (301–400 tortillas) periconceptional corn tortilla
intake during the first trimester was associated with
increased odds ratios (ORs) of having an NTD-affected
pregnancy (OR, 2.4; 95% confidence interval [CI],
1.1–5.3) compared with low (≤ 100 tortillas) pericon-
ceptional consumption, and no increased risks were
observed at high (≥ 400 tortillas) periconceptional con-
sumption. Missmer et al [8] suggested that maternal
fumonisin consumption increases the risk of NTD, and
the risk is proportional to dose up to a threshold level at
which point fetal death may occur. Fumonisins induce
NTDs by their apparent interference with folate utiliza-
tion. Fumonisins inhibit sphingolipid biosynthesis by the
inhibition of ceramide synthase [9]. The fumonisin-
induced sphingolipid deletion affects folate receptor-
mediated transport of 5-methyltetrahydrofolate and
results in folate deficiency and NTDs [10]. In mouse
models, fumonisin exposure induces NTDs [11–13], and
supplemental folic acid prevents fumonisin-induced
NTDs [12,13].
Periconceptional Zinc Deficiency
Zinc is necessary for fetal growth and development. It is
a constituent of hormones and neuropeptides [14], and
is essential for cell proliferation and differentiation [15].
Neonates born with NTDs have been found to have low
serum and/or hair zinc levels [16–19]. In animal models,
severely reduced maternal zinc intake in early gestation
results in NTDs in offspring [20]. In humans, zinc defi-
ciency is related to central nervous system malforma-
tions [21–25]. Sever [21] observed that chronic low
dietary zinc intake in Egypt, the Middle East, and among
Sikhs was associated with increased prevalence of NTDs.
Pregnant women with acrodermatitis enteropathica
are at risk for NTDs [22]. Acrodermatitis enteropathica
(OMIM 201100) is an autosomal recessive disorder
caused by mutation in the SLC39A4 (OMIM 607059)
gene. The SLC39A4 gene encodes the zinc transporter
protein ZIP4, which is essential for normal zinc home-
ostasis [26–31]. Acrodermatitis enteropathica is a dis-
order of zinc deficiency due to impaired absorption of
zinc from the gastrointestinal tract. The clinical features
of acrodermatitis enteropathica include alopecia, diar-
rhea, vascular dermatitis, dysfunction of humoral and
cellular immunity, and failure to thrive. Acrodermatitis
enteropathica can be treated by oral zinc supplemen-
tation with 3 mg/kg/day of elemental zinc [32]. In the
case of acrodermatitis enteropathica, the amount of
zinc supplementation may need to be increased during
pregnancy [33]. This is because pregnancy as well as oral
contraceptive use can cause a decrease in zinc concen-
tration, possibly due to the effect of estrogen [34–36].
Furthermore, prenatal iron supplementation can impair
zinc absorption [37,38]. Vegetarians, alcoholics and the
malnourished are at increased risk of zinc deficiency,
because the bioavailability of zinc in vegetarian diet with
abundant phylate is low, and alcoholics usually have
malnutrition, impaired zinc absorption and increased
urinary excretion of zinc [32]. Following zinc supplemen-
tation, the pregnancy outcome in women with acroder-
matitis enteropathica is good [39]. Zinc supplementation
is also beneficial in reducing the NTD risk in pregnant
women with chronic zinc deficiency and recurrent NTD
births [40–42]. Velie et al [43] proposed that the risk
of NTDs in fetuses and infants decreases with increas-
ing maternal periconceptional zinc intake, and inade-
quate maternal zinc intake is associated with increased
NTD risk. They observed that: (1) increased maternal
periconceptional zinc intake from all sources and from
the most bioavailable source such as animal products
was associated with decreased NTD risk; (2) low total
zinc intake in combination with high phytate intake was
associated with the highest risk for NTDs; (3) and the
association between total zinc intake and NTD risk was
not mediated by total folate intake or by sociodemo-
graphic factors. Groenen et al [44,45] concluded that
maternal zinc status is associated with the risk of spina
bifida in offspring. Groenen et al [44] found that the
maternal red blood cell zinc concentration was signifi-
cantly lower at 5% (95% CI, 0–9%) in mothers with
NTD offspring compared with the control mothers, and
the OR for maternal low zinc concentration in associa-
tion with spina bifida was 2.9 (95% CI, 1.2–7.0). Cengiz
et al [46] found that in women with second-trimester
induced abortion resulting from NTDs had significantly
lower serum zinc level (62.48 ± 15.9 vs. 102.6 ± 23.7),
and suggested zinc supplementation in addition to
folic acid supplementation to decrease the recurrence
and occurrence of NTDs. Bound et al [47] suggested
that lead may induce NTDs by reducing bioavailability
of zinc from food and indirectly causing zinc deficiency.
However, the suggestion is contrary to the results of
three studies: (1) Macdonell et al [48] found no corre-
lation between domestic water lead concentration and
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the prevalence of NTDs; (2) Carrillo-Ponce Mde et al
[18] found no correlation between NTDs and a high
level of serum lead in newborns; (3) and Brender et al
[49] found no significant difference in blood level of
lead between women with NTD-affected pregnancies
and women with normal live births. Brender et al [49]
suggested that maternal exposure to lead is probably
not a significant risk factor for NTDs in offspring.
Parental Occupational Exposure and
Residential Proximity to Pesticides
Parental occupational exposure and residential prox-
imity to teratogens have been associated with an in-
creased risk of NTDs in offspring. There is sufficient
evidence of the adverse reproductive effects of NTDs in
maternal or paternal exposure to pesticides and/or
agricultural work [50–61]. High-level pesticide expo-
sure may occur in pesticide applicators, manufacturers
and other agricultural workers, and moderate- and low-
level exposures may occur in the general populations
from residential pesticide use or dietary contamina-
tion. In a study in England on congenital malformations
among offspring of agricultural workers, Balarajan and
McDowall [50] observed that gardeners and grounds-
men who used herbicide experienced increased ratios
for spina bifida, anencephaly and facial clefts. In a study
in the Netherlands, Blatter et al [51] found an increased
risk of spina bifida in women working in agricultural
occupations (OR, 3.4; 95% CI, 1.3–9.0). In another
study also in the Netherlands, Blatter et al [52] found
an OR of 5.6 (95% CI, 1.8–17.81) for maternal agricul-
tural occupations. Blatter and Roeleveld [53] found
an increased risk of spina bifida in women working in
agricultural occupations in Sweden (OR, 1.8; 95% CI,
0.8–4.2). Blatter et al [54] found an association between
spina bifida and paternal pesticide occupational expo-
sure (OR, 1.7; 95% CI, 0.7–4.0). Blatter et al [55]
observed increased ORs for women in agricultural occu-
pations in Sweden (OR, 1.8; 95% CI, 0.8–4.2) and in
Spain (OR, 2.2; 95% CI, 0.8–5.9) but not in Hungary
(OR, 1.1; 95% CI, 0.7–1.7). In Spain, García et al [56]
found that the mothers who were involved in agricul-
tural activities during the month before conception
and the first trimester of pregnancy had an OR of 3.16
(95% CI, 1.11–9.01) for the risk of nervous system
defects, oral clefts and multiple anomalies; paternal
agricultural work did not increase the risk except that
the fathers, who reported ever handling pesticides, had
an OR of 1.49 (95% CI, 0.94–2.35) for nervous system
and musculoskeletal defects. In California, Shaw et al
[57] found that women living within 0.25 miles of an
agricultural crop had increased risks for offspring with
NTDs (OR, 1.5; 95% CI, 1.1–2.1), and Shaw et al [58]
also found that fathers who worked in farming, forestry
and fishing had an OR of 2.1 (95% CI, 1.3–3.3) for
NTDs. In Norway, Nordby et al [59] found that NTDs
was moderately associated with potato cultivation
(prevalence ratio [PR], 1.6; 95% CI, 1.1–2.3) and
paternal work of > 500 hours/year (PR, 1.6; 95% CI,
1.1–2.5), and suggested that there is a moderate asso-
ciation of exposure to mancozeb, a fungicide, with
NTDs. In California, Rull et al [60] observed that in-
creases in NTD risks were associated with maternal
residence within 1,000 m of agricultural applications
of benomyl, methyl carbamate  or organophosphorus
pesticides, or pesticides listed as endocrine disruptors,
cholinesterase inhibitors or developmental toxins. They
also found that cholinesterase inhibitors and organo-
phosphorus pesticides were specific for anencephaly,
and amides, benzimidazoles and methyl carbamates
were specific for spina bifida. Lacasaña et al [61] sug-
gested that maternal exposure to agricultural work is a
risk factor for NTDs, and paternal exposure to pesti-
cides in or prior to periconceptional period increases
the risk of having an anencephalic child. In Mexico,
Lacasaña et al [61] found that the children of mothers
who worked in agriculture in the acute risk period of 3
months before and 1 month after the last menstrua-
tion periods had a greater risk of anencephaly (OR,
4.57; 95% CI, 1.05–19.96), and the risk of fathers hav-
ing a child with anencephaly was greater in those who
applied pesticides either in the acute risk period (OR,
2.50; 95% CI, 0.73–8.64) or in the non-acute risk
period (OR, 2.03; 95% CI, 0.58–7.08). Lacasaña et al
[61] advised that women, who are involved in agricul-
tural work or living with men working in agriculture,
should be protected from direct and indirect pesticide
exposure, especially during the periconceptional period
if they are planning to have a child.
Lower Socioeconomic Status
NTDs have been reported in populations with lower
socioeconomic status (SES) as measured by education,
occupation and income [62–66]. Education reflects a
person’s ability to access and interpret health-related
information; occupation influences health via expo-
sure to work place hazards, psychosocial factors, and
social network; and income influences maternal health,
living condition, medical care, and lifestyle [62].
Wasserman et al [63] observed twofold elevated NTD
risks for several SES indicators and suggested that both
lower SES and residence in a lower-SES neighborhood
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increase the risk of an NTD-affected pregnancy. Farley
et al [64] found that low maternal education was a
strong predictor of having a child with an NTD (adjusted
OR [AOR], 1.8; 95% CI, 1.1–3.1) and suggested that
interventions should target women of low educational
status in order to further reduce the incidence of NTDs.
Meyer and Siega-Riz [65] observed that the decline in
spina bifida from 1995 to 1999 in North Carolina after
folic acid fortification varied considerably by sociode-
mographic subpopulations. In a Mexican study, Blanco
Muñoz et al [66] identified four groups of women that
may be especially vulnerable to NTDs, which included
women with less than a primary school education
(AOR, 3.0; 95% CI, 1.2–7.6), women with a primary
school education but without a completed junior high
school education (AOR, 2.2; 95% CI, 0.9–5.7), women
with a monthly income < US$100 (AOR, 2.5; 95% CI,
1.2–5.1), and women employed in industry or agricul-
ture during the acute period of 3 months prior to con-
ception to 1 month after conception (AOR, 6.5; 95%
CI, 1.4–29.6). In a large, multicentered, US case-control
study, Yang et al [62] found that maternal low educa-
tion was associated with anencephaly (AOR, 1.4; 95%
CI, 0.6–3.4), paternal operator/laborer occupation was
associated with spina bifida (AOR, 1.4; 95% CI,
1.0–2.0), and subjects with the lowest household SES
index had the greatest risk of anencephaly and spina
bifida (AOR, 2.3; 95% CI, 1.0–5.5).
Fetal Alcohol Syndrome
Fetal alcohol syndrome (FAS) is characterized by pre-
natal and postnatal onset of growth deficiency, mild-
to-moderate microcephaly, short palpebral fissures,
maxillary hypoplasia, a short nose, smooth philtrum
with a thin and smooth upper lip, joint anomalies, ven-
tricular septal defects, atrial septal defects, fine motor
dysfunction, irritability in infancy, hyperactivity in child-
hood, and varying degrees of mental retardation [67].
Most children with FAS are born to alcoholic women
whose intake is eight to ten drinks or more per day [67].
Occasional abnormalities of the central nervous system
associated with FAS include meningomyelocele, hydro-
cephalus, abnormalities of the corpus callosum, and
reduced sizes of the basal ganglia and cerebellar vermis
[67]. Using magnetic resonance imaging, Johnson et al
[68] found central nervous system abnormalities to be
associated with FAS, including agenesis and hypoplasia
of the corpus callosum, cavum septi pellucidi, cavum
vergae, ventriculomegaly, hypoplasia of inferior olivary
eminences, small brain stem and microencephaly. A po-
tential association between maternal early pregnancy
alcohol intake and NTDs has been described [69–75].
Clarren and Smith [69] observed one child with lum-
bar meningomyelocele and one child with lumbosacral
lipomeningocele among 65 cases of FAS. Goldstein
and Arulanantham [70] reported sacral myelomeningo-
cele and renal anomalies in a child with FAS. Clarren
[71] documented two infants with anencephaly born
to alcoholic mothers. Fuster et al [72] reported an infant
with sacral myelomeningocele and FAS. Friedman [73]
reported lumbosacral meningomyelocele in a child with
maternal alcohol ingestion. Castro-Gago et al [74]
reported four brothers with lumbosacral myelomeningo-
cele, with the excessive ingestion of alcohol by their
mother during the pregnancies being the only signifi-
cant factor. Kan et al [75] reported an infant with sacral
myelomeningocele, Arnold-Chiari malformation, and
FAS. Heavy drinking during pregnancy is well known to
be associated with congenital malformations. However,
whether light or moderate drinking is teratogenic is
controversial [76,77]. Shaw et al [78] reported that
maternal alcohol use did not reveal increased NTD
risks by their findings of periconceptional use of alco-
hol with < 1 drink/day (OR, 0.80; 95% CI, 0.62–1.0) or
≥1 drink/day (OR, 0.69; 95% CI, 0.4–1.2). Pathogenesis
of ethanol-induced NTDs includes oxidative stress,
folate deficiency, and involvement of the Sonic hedge-
hog (Shh) signaling. Oxidative stress and free radicals
have been shown to be associated with ethanol-induced
cytotoxicity in neural crest cells [79]. Ethanol-induced
NTDs are caused in part by ethanol inhibition of L1-
mediated cell adhesion [80]. Antioxidants that modu-
late the action of ethanol on the L1 cell adhesion
molecules can diminish the adverse effects of ethanol
[81,82]. Alcohol is also known to induce folate deficiency
[83]. Ethanol impairs methionine synthase activity,
alters methionine metabolism, and increases hepato-
cellular apoptosis and proliferation in micropigs [84].
Chronic consumption of alcohol selectively inhibits
active methionine absorption in the small intestine of
pregnant rats [85]. Ethanol acutely impairs the renal
conservation of 5-methyltetrahydrofolate in the iso-
lated perfused rat kidneys [86]. Chronic ethanol expo-
sure depletes serum and hepatic folate and causes
folate deficiency in rats [87]. Ethanol enhances urinary
folate excretion in chronically alcoholic monkeys [88].
Yanaguita et al [89] showed that supplementation
with the recommended dose of folic acid in rats was
not effective in preventing the deleterious teratogenic
effects induced by ethanol, indicating the need for an
increased dose of folic acid in ethanol-treated mice.
Shh signaling cascade is involved in the molecular patho-
genesis of FAS [90,91]. Ahlgren et al [90] reported
that neural crest cell death in chick embryos exposed
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to excessive ethanol was associated with downregu-
lation of Shh signaling cascade. On the contrary,
Yamada et al [91] found that craniofacial anomalies in
mouse embryos exposed to high ethanol were asso-
ciated with increased expression of Shh signaling 
cascade genes.
Mutations in the VANGL1 Gene
The VANGL2 gene (OMIM 600533) encodes a homolog
of Drosophila Strabismus/Van Gogh (Stbm/Vang), a high-
ly conserved planar cell polarity protein initially involved
in the frizzled-disheveled tissue polarity pathway in
Drosophila [92]. Loop-tail (Lp) is a semidominant mouse
mutation in which the Vangl2 gene is mutated and the
Lp/+ mouse heterozygotes display urogenital defects
and a looped tail. Vangl2 is expressed along the neural
tube at the time of closure [92]. In Lp/Lp mouse homozy-
gotes, homozygosity for loss-of-function alleles at Vangl2
causes craniorachischisis and in utero death [92]. There
is a second VANGL gene, VANGL1 (OMIM 610132), in
vertebrates. VANGL1 and VANGL2 proteins share 73.1%
similarity [93]. In humans, heterozygosity for mutant
variants of VANGL1 is associated with NTDs [94]. Kibar
et al [94] identified independent mutations (V239I,
R274Q and M328T) in the human VANGL1 gene in
three patients in a cohort of 144 patients representing
sporadic and familial cases of NTDs. In a 10-year-old
Italian girl with caudal regression syndrome, lipomyelo-
schisis, anorectal malformation, hydromelia and teth-
ered spinal cord, Kibar et al [94] detected a missense
mutation V239I, resulting in the substitution of valine
with isoleucine in VANGL1. The V239I mutation was
present in her mother, who showed no clinical signs of
NTDs, and in her brother, who had only dermal sinus,
but not in her father. In a 19-year-old Italian girl with
lumbosacral myelomeningocele, hydrocephalus and
congenital club feet, Kibar et al [94] detected a mis-
sense mutation R274Q, resulting in the substitution of
arginine with glutamine in VANGL1. The R274Q muta-
tion was present in her mother but not in her father.
Her mother and maternal aunt had vertebral schisis. In
a 21-year-old woman with sporadic disease of lum-
bosacral myelomeningocele, hydrocephalus, Chiari II
malformation, tethered spinal cord, club feet, lumbo-
sacral scoliosis and sacrococcygeal kyphosis, Kibar et al
[94] detected a missense mutation M328T, resulting
in the substitution of methionine with threonine in
VANGL1. In their study, only a small proportion of NTD
patients had heterozygous mutations in VANGL1, and
there was incomplete penetrance, indicating that other
environmental factors and/or sensitizing genetic lesions
may also play a role in the pathogenesis of NTDs.
Torban et al [95] hypothesized that partial loss of
VANGL2 function may be one of such sensitizing genetic
lesions, and suggested that VANGL1 functions in the
mammalian planar cell polarity pathway and acts in con-
cert with VANGL2 to control neural tube formation.
Human Athymic Nude/SCID Fetus
Amorosi et al [96] reported a 15-week-gestation female
human fetus homozygous for the R255X mutation in
the FOXN1 gene, who had multiple anomalies including
anencephaly, spina bifida, abnormal skin and lack of
thymus. Nude/SCID phenotype (OMIM 601705) is
characterized by severe combined immunodeficiency
(SCID) syndrome, congenital alopecia, and nail dystro-
phy [97]. Nude/SCID phenotype is an autosomal reces-
sive disorder caused by homozygous mutation in the
FOXN1 gene (WHN; OMIM 600838) [98]. Foxn1 is impli-
cated in mouse cutaneous and thymic epithelial devel-
opment and is associated with the mouse nude (nu)
mutations [99,100]. Amorosi et al [96] found that Foxn1
gene was expressed in the mouse developing choroid
plexus cyst and suggested that FOXN1 may be involved
in neurulation in humans.
Single Nucleotide Polymorphism 
(SNP) in the NOS3 Gene
Nitric oxide (NO) inhibits methionine synthase activity
and interferes with homocysteine remethylation [101]
and proper neurulation [102–104]. Endothelial nitric
oxide synthase 3 (NOS3) is expressed constitutively in
endothelial cells and is responsible for vascular NO
production. The single nucleotide polymorphism (SNP)
NOS3 G894T SNP (NOS3 Glu298Asp) in the NOS3
gene (OMIM 163729) has been shown to be associ-
ated with susceptibility to late-onset Alzheimer disease
[105,106], pregnancy-induced hypertension [107],
placental abruption [108,109], resistance to conven-
tional antihypertensive therapy [110], ischemic heart
disease [111], coronary spasm [112], angiographic
coronary artery disease [113], ischemic stroke, [114]
and NTDs [115,116]. The NOS3 894TT genotype is
associated with plasma hyperhomocysteinemia in
cases with a low serum folate concentration [117].
Brown et al [115] found that embryonic NOS3 G894T
genotype was significantly associated with the risk of
spina bifida. van der Linden et al [116] found that the
NOS3 894TT genotype did not increase spina bifida
risk in mothers (OR, 1.50; 95% CI, 0.71–3.19) and in
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children (OR, 1.78; 95% CI, 0.75–4.25). However, they
found that maternal NOS3 894GT/TT genotype in-
creased the maternal risk of having a spina bifida-
affected child, in combination with either a maternal
MTHFR 677T T genotype (OR, 4.52; 95% CI, 1.55–13.22)
or an elevated plasma homocysteine (OR, 3.38; 95%
CI, 1.46–7.84).
Conclusion
This article provides a comprehensive review of syn-
dromes, disorders, and maternal and fetal risk factors
associated with NTDs, including maternal fumonisin
consumption, periconceptional zinc deficiency, parental
occupational exposure and residential proximity to
pesticides, lower socioeconomic status, FAS, mutations
in the VANGL1 gene, human athymic Nude/SCID fetus,
and SNP in the NOS3 gene. NTDs associated with syn-
dromes, disorders, and maternal and fetal risk factors
are a rare but important cause of NTDs. The recurrence
risk and the preventive effect of maternal folic acid intake
in NTDs associated with syndromes, disorders, and
maternal and fetal risk factors may be different from
those of nonsyndromic multifactorial NTDs. Perinatal
diagnosis of NTDs should alert doctors to the syn-
dromes, disorders, and maternal and fetal risk factors
associated with NTDs, and prompt thorough etiologic
investigation and genetic counseling.
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